Sectoral Asset Management’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Other funds holding CTNM
Sectoral Asset Management's CTNM Position: Q3 2026 in Review
Sectoral Asset Management reduced its Contineum Therapeutics (CTNM) stake by 5.2% in Q3 2026, selling an estimated $566K and leaving 689,587 shares worth $9.25M. The position accounts for 5.88% of the portfolio, ranked #2.
Sectoral Asset Management first reported a position in CTNM in Q2 2024 and has held it in 10 quarters since. The position peaked at $15.3M in Q3 2024. 118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.
- Sectoral Asset Management held 689,587 shares of Contineum Therapeutics worth $9.25M as of Q3 2026.
- Sectoral Asset Management sold 38,000 Contineum Therapeutics shares in Q3 2026, an estimated $566K.
- Contineum Therapeutics made up 5.88% of Sectoral Asset Management's portfolio in Q3 2026, its #2 holding.
- Sectoral Asset Management first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 10 quarters since.
- Sectoral Asset Management's Contineum Therapeutics position peaked at $15.3M in Q3 2024.
- 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.
Based on Sectoral Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.